This award funds research focused on improving lung cancer patient health outcomes and survivorship through evidence-based, patient-centered approaches. Projects must align with FY26 Lung Cancer Research Program priorities in Health Outcomes and Survivorship and may include translational or clinical research, including pilot clinical trials. A lung cancer patient or caregiver advocate must be part of the research team.
Open to any type of entity, with the requirement that the research team includes a lung cancer patient/survivor or caregiver advocate. Additional eligibility clarifications may apply.
